The arrival of safe and effective novel coronavirus vaccines is a great development in the coronavirus pandemic. There are some recommended vaccines that are in use to help and save people who come in contact with the virus.
Here are the names of some the lifesaving jabs for COVID-19:
- Pfizer-BioNTech COVID-19 vaccine: The Pfizer-BioNTech COVID-19 vaccine is 95% effective in saving people with the novel coronavirus virus symptoms. This vaccine is recommended for people age 16 and more. It requires two jabs given 21 days apart. The second dose can be given up to six weeks after the first dose, if required.
- Moderna COVID-19 vaccine. The Moderna COVID-19 vaccine is 94% helpful in preventing people with the COVID-19 symptoms. This vaccine is for people age 18 and above. It requires two jabs given 28 days apart. The second dose of injection can be given up to six weeks after the first one.
- The Covishield and Covaxin—the two COVID-19 vaccines are presently used in India—have effectiveness against the ‘Indian strain’ and show “milder” sickness in case of infection post vaccination, a senior scientist said on quoting initial results of a study. “Initial positive neutralisation studies of B.1.617, with both post-Covaxin or Covishield sera, are correlatable with milder disease during post-vaccination breakthrough infections. This is a positive while we get quantitative data for better understanding of infection protection,” Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology tweeted.
According to study by the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad with the CSIR propose that early outcome using in-vitro neutralisation evaluation proves that both convalescent (prior infection) serum and Covishield-vaccinated serum gives protection against the B.1.617 variant.
The severe illness in vaccinated people are entirely normal.
“There will be a small percentage of people who are fully vaccinated who still get sick, are hospitalized, or die from COVID-19,” the CDC statesTrusted Source.